OA-65 Overall Survival (OS) With Ciltacabtagene Autoleucel (Cilta-cel) Versus Standard of Care (SoC) in Lenalidomide (Len)-Refractory Multiple Myeloma (MM): Phase 3 CARTITUDE-4 Study Update

María-Victoria Mateos, Jesús F. San Miguel, Binod Dhakal, Cyrille Touzeau, Xavier Leleu, Niels W.C.J. van de Donk, Surbhi Sidana, Albert Oriol, Yaël C. Cohen, Simon J Harrison, Hermann Einsele, Paolo Corradini, Diana Chen, Quanlin Li, Katherine Li, Ana Slaughter, Carolina Lonardi, Nina Benachour, Martin Vogel, Nikoletta Lendvai, Mythili Koneru, Nitin Patel, Erika Florendo, P. Joy Ho, Rakesh Popat